Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Denosumab: A Potential Treatment Option for Aneurysmal Bone Cysts

NCT03415477 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT03415477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03415477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Denosumab: A Potential Treatment Option for Aneurysmal Bone Cysts
Lead sponsor
Peking University People's Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
January 1, 2014
Completion date
December 31, 2017
Enrollment
6 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bone cyst aneurysmal, pathological fracture, recurrent disease, refractory tumor